الفهرس Only 14 pages are availabe for public view
 |  | from | 183 |  |  |
| | | from | 183 | | |
Abstract
Hepatitis C virus (HCV) infection has been associated with the development of B-cell non-Hodgkin lymphoma (including diffuse large B-cell lymphoma, marginal zone lymphoma, lymphoplasmacytic lymphoma, and extranodal marginal zone B cell lymphoma of mucosa- associated lymphoid tissue) as well as primary hepatic lymphoma . In addition, HCV infection may increase the risk of hepatotoxicity related to treatment for lymphoma. The risk of NHL was increased in patients with HCV compared with non-HCV infected individuals. Lymphoma may develop due to the progression of cryoglobulinemia. One hypothesis is that cryoglobulinemia arises from chronic stimulation of the immune system by HCV, predisposing to a lymphoproliferative disorder. Some data suggest that successful treatment of HCV may reduce the risk of lymphoma in patients who achieve a sustained virologic response